Hemolysis upon intravenous immunoglobulin transfusion.

  • Ruth F. Padmore
  • Published 2012 in
    Transfusion and apheresis science : official…

Abstract

Intravenous immunoglobulin (IVIG) is a mainstay of therapy in many disorders. An uncommon adverse side effect is IVIG-related hemolysis. Risk factors for IVIG-related hemolysis have been identified, including high dose IVIG given to non-O blood group recipients with an underlying inflammatory state. IVIG-related hemolysis has been linked to anti-A and anti… (More)
DOI: 10.1016/j.transci.2011.11.004

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics